{
  "id": 15036043,
  "title": "The next big shake-up in the GLP-1 market? (Part 1 of 3)",
  "url": "https://urgent.news/2026/10/16/the-next-big-shake-up-in-the-glp-1-market-part-1-of-3",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T08:08:25.000Z",
  "source": {
    "name": "Labiotech",
    "slug": "labiotech",
    "url": "https://www.labiotech.eu/podcast/the-next-big-shake-up-in-the-glp-1-market-part-1-of-3/"
  },
  "original_language": "en",
  "account": null,
  "summary": "In part one of our series, I’m joined by Valeriia Simanovskaia, founder and CEO of BioBrokers, an independent capital markets and strategic advisory firm for life sciences. The post The next big shake-up in the GLP-1 market? (Part 1 of 3) appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}